{"gene":"HBB","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1981,"finding":"A 72-bp repeated sequence element in SV40 DNA (transcriptional enhancer) acts in cis to increase beta-globin gene transcription ~200-fold; the element functions in either orientation and at positions up to 1400 bp upstream or 3300 bp downstream of the beta-globin transcription initiation site.","method":"Transient transfection of HeLa cells with beta-globin gene-SV40 recombinant plasmids; S1 nuclease hybridization assay; immunofluorescent staining for beta-globin protein","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in transfected cells with systematic deletion/orientation mutants, multiple orthogonal readouts (RNA and protein), foundational enhancer study","pmids":["6277502"],"is_preprint":false},{"year":1982,"finding":"Efficient transcription of the rabbit beta-globin gene in vivo requires both the ATA (TATA) box and a region between -100 and -58 bp upstream of the transcription start site; deletion of either region reduces transcript levels ~10-fold, and deletion of the ATA box also abolishes initiation-site specificity. Sequences downstream of the ATA box, including the natural cap site, are dispensable.","method":"Deletion mutagenesis of the rabbit beta-globin gene introduced into HeLa cells via SV40-plasmid recombinants; S1 nuclease quantitation of beta-globin transcripts","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic promoter deletion mutagenesis with quantitative RNA readout, multiple mutants tested","pmids":["6276753"],"is_preprint":false},{"year":1983,"finding":"An SV40-globin hybrid transcript is produced and translated in infected monkey cells only when the construct retains a ~500 bp SV40 RNA splicing region; deletion of this splicing region abolishes stable globin transcript accumulation and beta-globin protein production.","method":"Construction of SV40-beta-globin recombinant viruses with defined deletions; radioimmunoassay for beta-globin protein; RNA analysis in infected monkey cells","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — deletion mutagenesis and protein detection, single lab study","pmids":["225043"],"is_preprint":false},{"year":1981,"finding":"The rabbit beta-globin promoter is recognized and transcripts are correctly spliced when the gene is expressed in Xenopus laevis frog embryos, demonstrating conservation of the basic transcriptional and splicing machinery across vertebrates.","method":"Microinjection of rabbit beta-globin gene into fertilized Xenopus eggs; S1 nuclease mapping of transcripts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo expression assay with RNA-level verification, single lab","pmids":["6946453"],"is_preprint":false},{"year":1981,"finding":"The largest beta-globin pre-mRNA is co-linear with the gene and contains both intervening sequences; splicing proceeds stepwise, with removal of the small intron (IVS1) generally preceding removal of the large intron (IVS2), generating partially spliced intermediates.","method":"S1 nuclease mapping of RNA from rabbit bone marrow","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct S1 mapping of endogenous bone marrow RNA with multiple partially spliced intermediates characterized","pmids":["7471214"],"is_preprint":false},{"year":1982,"finding":"Human beta-globin pre-mRNA is accurately spliced in vitro by HeLa cell whole-cell extracts; the small intervening sequence is removed precisely, yielding a junction sequence identical to authentic reticulocyte beta-globin mRNA. A transcript terminated upstream of the polyadenylation site is spliced most efficiently, whereas one terminated downstream is not spliced.","method":"In vitro splicing assay with HeLa cell extracts; primer extension analysis of splice junctions","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution in vitro with sequence verification of splice junction","pmids":["6292841"],"is_preprint":false},{"year":1983,"finding":"The human beta-globin promoter and coding sequences are transcribed by RNA polymerase III (in addition to Pol II); these Pol III transcripts are polyadenylated, probably spliced, and detectable in bone marrow and reticulocytes. Their 5' boundaries map near an Alu-related Pol III promoter consensus sequence between -235 and the cap site.","method":"In vitro transcription with alpha-amanitin sensitivity assay; in vivo RNA analysis in bone marrow and reticulocytes","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition plus in vitro and in vivo RNA detection, single lab","pmids":["6194893"],"is_preprint":false},{"year":1984,"finding":"Induction of beta-globin gene expression in murine erythroleukemia (MEL) cells requires DNA sequences both 5' and 3' of the translation initiation site; hybrid gene experiments show that the 3' beta-globin sequences (coding region) are sufficient to confer inducibility on heterologous promoters, and nuclear run-on confirms induction is at least partly transcriptional.","method":"Introduction of deletion mutants and hybrid genes (beta/gamma, beta/H-2Kbm1) into MEL cells; S1 nuclease analysis before and after differentiation; nuclear run-on transcription assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis in differentiation model with nuclear run-on, multiple constructs tested","pmids":["6088069"],"is_preprint":false},{"year":1983,"finding":"Induction of the beta-globin gene during MEL cell differentiation results at least in part from increased transcription rate, as shown by nuclear transcription (run-on) experiments; both the intact human beta-globin gene and a hybrid mouse-human beta-globin gene are inducible, indicating the regulatory sequences are conserved between mouse and human.","method":"Stable cotransformation of MEL cells; S1 nuclease and primer extension analysis; nuclear transcription run-on experiments","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — nuclear run-on transcription assay plus mRNA analysis with multiple constructs, single lab","pmids":["6572107"],"is_preprint":false},{"year":1985,"finding":"Human beta-globin gene expression in transgenic mice is restricted to erythroid lineage cells; constructs with as little as 48 bp of 5'-flanking sequence drive erythroid-specific, temporally correct expression. mRNA transcripts have correct 5' ends and direct beta-globin protein synthesis, and human beta-globin protein is detectable in mature erythrocytes.","method":"Pronuclear microinjection to generate transgenic mice; S1 nuclease/primer extension for RNA analysis; reticulocyte lysate translation; protein detection in erythrocytes","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic model with RNA and protein readouts, multiple constructs, replicated across 20 transgenic lines","pmids":["2992937"],"is_preprint":false},{"year":1988,"finding":"A chicken erythroid cell-specific enhancer in the intergenic region between adult beta- and embryonic epsilon-globin genes activates transcription of both; correct developmental stage-specific regulation of beta-globin requires interaction of the beta-globin enhancer with a positive regulatory element (the developmental stage selector element, SSE) within the adult beta-globin promoter.","method":"Deletion and substitution mutant analysis in avian erythroid cells; transient transfection assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic promoter and enhancer mutagenesis with functional readout in erythroid cells, multiple mutants","pmids":["3167976"],"is_preprint":false},{"year":1988,"finding":"Premature translation termination (nonsense) mutations in the human beta-globin gene decrease steady-state mRNA levels; this effect is observed for all five nonsense mutations tested (at codons 15, 17, 26, 39, 112) but not for two missense mutations, indicating that the presence of a stop codon per se—regardless of position or type—correlates with reduced mRNA accumulation.","method":"Heterologous transfection of cloned beta-globin genes carrying defined point mutations; steady-state mRNA quantitation by S1 nuclease assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple allelic series tested in parallel transfection system, replicated across five nonsense and two missense mutations","pmids":["3353367"],"is_preprint":false},{"year":1992,"finding":"The beta-39 nonsense mutation reduces beta-globin mRNA accumulation at a step prior to cytoplasmic accumulation (i.e., a nuclear/pre-cytoplasmic step); cytoplasmic mRNA stability, splicing accuracy, and polyadenylation are not affected, pointing to a defect in nuclear mRNA metabolism.","method":"Transfection into cell lines carrying temperature-sensitive RNA Pol II; analysis of transcription rate, mRNA stability, splicing accuracy, and polyadenylation separately","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal RNA metabolism steps assayed in a single well-controlled study with ts-Pol II cells","pmids":["1557399"],"is_preprint":false},{"year":1990,"finding":"Human gamma-to-beta globin switching in transgenic mice is restored when both gamma- and beta-globin genes compete together for interaction with the LCR hypersensitive (HS) sequences; when HS sequences are fused individually to either gene alone, high expression is achieved but temporal specificity is lost, demonstrating that developmental switching results from gene competition for LCR interaction.","method":"Transgenic mice with LCR HS sequences fused to individual globin genes or combined gamma+beta locus fragments; developmental expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic competition assay with multiple construct comparisons, mechanistic epistasis established","pmids":["1692558"],"is_preprint":false},{"year":1996,"finding":"EKLF (erythroid Krüppel-like factor) is required for beta-globin gene transcription and for stabilizing LCR-beta-globin promoter interaction; in EKLF knockout mice the beta-globin promoter chromatin structure is altered, beta-gene transcription is absent, and gamma-gene transcription increases reciprocally. This demonstrates EKLF plays a major role in gamma/beta competition.","method":"Compound EKLF knockout / human beta-locus transgenic mice; single-cell transcription analysis; chromatin structure analysis at beta-globin promoter","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in vivo with chromatin structure readout, multiple genotypes compared","pmids":["8918890"],"is_preprint":false},{"year":1988,"finding":"DNA replication is required for transcriptional activation of the Xenopus beta-globin gene in HeLa cell transfections; replication does not act through covalent template modification or simply by increasing copy number, and only replicating templates are transcribed even when co-transfected with non-replicating templates, indicating a direct mechanistic role for replication in gene activation.","method":"Transfection of replicating vs. non-replicating Xenopus beta-globin constructs in HeLa cells; co-transfection experiments; copy number analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — controlled co-transfection design with multiple mechanistic controls, single lab","pmids":["2835669"],"is_preprint":false},{"year":1994,"finding":"Assembly of the chick beta-globin gene locus into synthetic nuclei using Xenopus egg extracts in an erythroid protein environment recapitulates tissue-specific chromatin structure and long-range promoter-enhancer interaction, leading to beta-globin gene activation; nucleosome-repressed templates can be reactivated by DNA replication in the presence of staged erythroid proteins via chromatin remodeling at the promoter and re-establishment of distal enhancer-promoter communication.","method":"Synthetic nuclei reconstitution using Xenopus egg extracts; chromatin assembly; transcription assays with erythroid vs. non-erythroid protein extracts","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution with chromatin assembly and functional transcription readout, demonstrates promoter-enhancer communication mechanistically","pmids":["7958909"],"is_preprint":false},{"year":1997,"finding":"Novel intergenic nuclear transcripts span the LCR and intergenic regions of the human beta-globin locus in erythroid cells; transient transfection of a beta-globin gene (epsilon, gamma, or beta) induces transcription of the chromosomal LCR and intergenic regions in nonerythroid cells (transinduction) by a mechanism requiring transcription of the plasmid but not protein expression. The plasmid co-localizes with the endogenous locus as shown by in situ hybridization.","method":"Nuclear run-on transcription analysis; transient transfection; fluorescence in situ hybridization (FISH) for co-localization","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — nuclear run-on plus FISH co-localization, single lab, mechanistic novelty","pmids":["9334315"],"is_preprint":false},{"year":2001,"finding":"Nuclear ferritin-H specifically binds the CAGTGC motif at position -153 to -148 bp of the human beta-globin promoter; mutation of this motif reduces binding 20-fold in competition gel-shift assays and abolishes ferritin-H-mediated repression of beta-globin promoter-driven reporter expression in cotransfected cells, demonstrating ferritin-H functions as a sequence-specific repressor of the beta-globin gene.","method":"Electrophoretic mobility shift assay (EMSA)/competition gel-shift with K562 nuclear extracts and purified human ferritin-H; site-directed mutagenesis of promoter; reporter gene cotransfection with EKLF and ferritin-H expression vectors in CV-1 cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — DNA-binding assay with purified protein plus mutagenesis of binding site linked to functional reporter assay, two orthogonal methods","pmids":["11481480"],"is_preprint":false},{"year":2003,"finding":"An erythroid-specific spatial cluster of cis-regulatory elements (active chromatin hub, ACH) forms around the beta-globin LCR and the active globin gene; the core ACH (HS1-HS6 plus upstream 5'HS-60/-62 and downstream 3'HS1) is developmentally conserved in mice and humans. Individual globin genes switch their physical interaction with this cluster during development correlating with changes in their transcriptional activity; in committed erythroid progenitors prior to beta-globin expression only LCR 5'-side interactions are stably present.","method":"Chromosome conformation capture (3C); DNase I hypersensitivity; developmental stage analysis in mouse and human erythroid cells","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — 3C chromatin interaction mapping across multiple developmental stages in two species, replicated","pmids":["14517543"],"is_preprint":false},{"year":2004,"finding":"Thalassemia mutations in the 5'UTR of the human beta-globin gene (+10(-T), +22(G>A), +33(C>G), +(40-43)(-AAAC)) reduce steady-state mRNA levels 15-38%; nuclear run-on experiments show that +10(-T) and +33(C>G) reduce the transcription rate (disrupting downstream promoter sequences), while +22(G>A) primarily acts post-transcriptionally; none affect mRNA transport, 3' end processing, or cytoplasmic stability.","method":"Stable transfection in MEL cells under LCR control; S1 nuclease/RNA quantitation; nuclear run-on; RNA stability assays; nuclear/cytoplasmic fractionation","journal":"British journal of haematology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal RNA metabolism assays with allelic series in stable chromatin context","pmids":["15009072"],"is_preprint":false},{"year":2007,"finding":"An intact HS2 enhancer that recruits RNA Pol II is required for intergenic transcription and histone H3 acetylation and H3K4 methylation between the enhancer and the epsilon-globin target gene; however, intergenic transcription and histone modifications are not sufficient for target gene transcription, which additionally requires initiation at the TATA box of the target gene—indicating intergenic and genic transcription complexes are independent.","method":"Chromatin immunoprecipitation (ChIP) for H3 acetylation and H3K4 methylation; model locus with HS2-epsilon-globin in chromatin; enhancer deletion analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP with enhancer deletion in chromatin model, mechanistically dissects intergenic vs. genic transcription","pmids":["17283048"],"is_preprint":false},{"year":2010,"finding":"PRMT1-catalyzed asymmetric dimethylation of H4R3 at the beta-globin locus directly enhances histone H3 acetylation (Lys9/Lys14) in vitro by providing a binding surface for PCAF; these modifications are required for efficient LCR-beta-promoter looping, transcription complex recruitment, and beta-globin transcription. PRMT1 knockdown prevents H3 acetylation, LCR-promoter interaction, and erythroid differentiation, all rescued by re-introduction of PRMT1.","method":"In vitro histone acetyltransferase assay with dimethyl-H4R3 substrate; co-immunoprecipitation of PCAF with modified H4R3; shRNA knockdown of PRMT1 in MEL erythroid progenitors; ChIP; 3C for LCR-promoter interaction; rescue experiment with rat PRMT1","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical assay plus mutagenesis context, knockdown/rescue, ChIP, and 3C chromatin looping assay, multiple orthogonal methods","pmids":["20068219"],"is_preprint":false},{"year":2010,"finding":"KLF1 knockdown in human and mouse adult erythroid progenitors markedly reduces BCL11A expression and increases gamma-globin/beta-globin expression ratios, indicating KLF1 controls globin switching by directly activating beta-globin and indirectly repressing gamma-globin through BCL11A.","method":"shRNA knockdown of KLF1 in human and mouse adult erythroid progenitors; quantitative RT-PCR for BCL11A, gamma-globin, and beta-globin","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function in two species with defined molecular pathway placement (KLF1→BCL11A→gamma/beta ratio)","pmids":["20676097"],"is_preprint":false},{"year":2011,"finding":"Upon erythroid differentiation, cohesin and its loading factor Nipbl bind the beta-globin LCR and the activated globin gene; Nipbl-dependent cohesin binding is required for long-range chromatin interactions between CTCF insulator elements and between the LCR distal enhancer and the target globin gene, the latter being critical for globin gene expression in vivo and in vitro.","method":"ChIP for cohesin and Nipbl occupancy; chromosome conformation capture (3C); siRNA knockdown of Nipbl; analysis in differentiating MEL and primary erythroid cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, 3C, and RNAi knockdown with functional gene expression readout, multiple complementary methods","pmids":["21454523"],"is_preprint":false},{"year":2013,"finding":"Three peripheral targeting regions (PTRs) in the HBB BAC drive nuclear peripheral localization of the beta-globin locus; targeting to both peripheral and pericentric heterochromatin depends on Suv39H-mediated H3K9me3 methylation across hundreds of kilobases around HBB, and peripheral tethering of the endogenous HBB locus additionally requires G9a-mediated H3K9me2 in flanking lamin-associated domains.","method":"BAC transgenesis; FISH; siRNA knockdown of Suv39H and G9a; chromatin fractionation; ChIP for H3K9me2/3","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — BAC transgene + endogenous locus analysis + knockdown + FISH + ChIP, multiple orthogonal methods in single study","pmids":["24297746"],"is_preprint":false},{"year":1998,"finding":"Replacement of the murine beta-globin genes with the human betaIVS-2-654 C>T thalassemic gene by gene targeting shows that this mutation causes the same aberrant RNA splicing in mice as in humans; no homozygous mice survive postnatally, and heterozygotes show reduced mouse beta-globin, no human beta-globin, and moderate beta-thalassemia.","method":"Homologous recombination gene targeting in mouse embryonic stem cells ('plug and socket' method); RNA splicing analysis; hematological characterization of heterozygous mice","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — precise gene targeting in vivo with splicing analysis and hematological phenotype, replicates human disease mechanism","pmids":["9490703"],"is_preprint":false},{"year":2002,"finding":"A T>G mutation at nucleotide 705 of human beta-globin intron 2 creates an aberrant 5' splice site that dominates over the correct splice sites; at temperatures below 30°C this aberrant splicing is inhibited and correct splicing is restored, demonstrating that temperature is a parameter affecting splice site selection in this thalassemic context.","method":"Stable cell lines (HeLa, K562) carrying IVS2-705 or IVS2-745 beta-globin constructs; culture at varying temperatures; RT-PCR analysis of splicing products","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined mutation in stable cell lines, temperature-dose response, single lab","pmids":["12409448"],"is_preprint":false},{"year":1995,"finding":"The second intron (IVS2) of the human beta-globin gene contains four GATA-1 binding sites, two Oct-1 binding sites, two SATB1 binding sites, and a potential homeobox protein binding site, as identified by DNase I footprinting and EMSA of the entire IVS2.","method":"DNase I footprinting of entire beta-globin IVS2; electrophoretic mobility shift assay (EMSA); antibody supershift for GATA-1, NFE-2, YY1, Oct-1","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — comprehensive footprinting and EMSA across entire intron, single lab, binding sites identified but functional role inferred","pmids":["7499351"],"is_preprint":false},{"year":2019,"finding":"CRISPR/Cas9 (targeting IVS1-110G>A mutation) and Cas12a/Cpf1 (targeting IVS2-654C>T mutation) RNP complexes achieve high-efficiency disruption of aberrant splice sites in primary CD34+ HSPCs from beta-thalassemia patients; erythroid progeny of edited cells show reversal of aberrant splicing and restoration of beta-globin expression.","method":"CRISPR RNP electroporation into primary CD34+ HSPCs; erythroid differentiation; RT-PCR for splicing; globin chain HPLC for beta-globin protein restoration","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — therapeutic editing in primary human HSPCs with functional protein readout, two distinct mutations and nucleases tested","pmids":["30704988"],"is_preprint":false},{"year":2020,"finding":"CRISPR-Cas9-mediated reduction of beta-globin in differentiating erythroid precursors is sufficient to induce robust re-expression of gamma-globin; RNA-seq identifies ATF4 as a causal regulator of this stress response—ATF4 binds the HBS1L-MYB intergenic enhancer and regulates MYB, which in turn controls BCL11A and gamma-globin levels.","method":"CRISPR-Cas9 knockout of HBB in isogenic erythroid precursors; RNA-seq; ATF4 ChIP at HBS1L-MYB enhancer; quantitation of MYB, BCL11A, and globin expression","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic CRISPR model plus ChIP for ATF4 binding, single lab, pathway placement via RNA-seq and ChIP","pmids":["32755585"],"is_preprint":false},{"year":2024,"finding":"HBB (hemoglobin subunit beta) is a direct molecular target of aconitine (AC) in cell-free hemoglobin; AC binding to HBB enhances HBB-ABHD5 and HBB-AMPK binding, leading to decreased HDAC-NT generation and cardiomyocyte death. HBB overexpression exacerbates AC-induced cardiotoxicity while HBB knockdown attenuates cardiomyocyte death. AC-triggered hemolysis releases HBB which scavenges NO, decreasing cardioprotective S-nitrosylation.","method":"RNA-seq in DO mice; HBB overexpression and knockdown in cardiomyocytes; cell-free binding assay for AC-HBB interaction; co-immunoprecipitation of HBB with ABHD5 and AMPK; measurement of S-nitrosylation and HDAC-NT","journal":"Acta pharmacologica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression/knockdown with protein interaction data (Co-IP) and functional readout, single lab","pmids":["38467717"],"is_preprint":false},{"year":2016,"finding":"The beta subunit of hemoglobin (HBB) acts as a lung-derived antimetastatic factor; a short C-terminal peptide region (Metox) is responsible for activity. HBB and the Metox peptide mediate growth arrest and apoptosis of neuroblastoma and other cancer cell lines in vitro, and Metox administration in xenograft models limits adrenal tumor development and spontaneous lung and bone marrow metastases. HBB2 is produced by alveolar epithelial and endothelial cells and is upregulated in mice bearing undetectable metastases.","method":"Peptide mapping/fractionation of lung-derived soluble factors; in vitro viability/apoptosis assays; xenograft mouse models; IHC/expression studies for cellular source","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — peptide mapping plus in vitro and in vivo functional assays, single lab, non-erythroid context","pmids":["27793844"],"is_preprint":false},{"year":2010,"finding":"HBB (beta-globin) mRNA and protein are expressed in neurons of the brain and are increased in the perihematomal zone after intracerebral hemorrhage; hemin upregulates HBB mRNA in cultured neurons, and this is reduced by the iron chelator deferoxamine, indicating a role for iron/heme signaling in neuronal HBB regulation.","method":"In vivo ICH rat model with time-course; in vitro cultured neurons exposed to hemin ± deferoxamine; qRT-PCR and Western blot; immunolocalization","journal":"Translational stroke research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — expression and localization data with pharmacological manipulation, single lab, no direct mechanistic pathway established","pmids":["20563289"],"is_preprint":false}],"current_model":"HBB (beta-globin) is transcriptionally activated in erythroid cells through a hierarchical mechanism in which the locus control region (LCR) physically loops to contact the active beta-globin promoter (active chromatin hub), a process mediated by cohesin/Nipbl binding, PRMT1-catalyzed H4R3 dimethylation that recruits PCAF for H3 acetylation, and the transcription factor KLF1 (which directly activates beta-globin and indirectly represses gamma-globin via BCL11A); promoter activity requires the TATA box and a −100 to −58 bp upstream element, and is repressible by nuclear ferritin-H binding a −150 CAGTGC motif; beta-globin pre-mRNA is processed by stepwise splicing (IVS1 before IVS2) and nonsense mutations reduce mRNA accumulation at a nuclear pre-cytoplasmic step via NMD-like surveillance; peripheral nuclear positioning of the HBB locus depends on Suv39H/G9a-mediated H3K9 methylation; and outside erythroid cells, HBB protein functions as a lung-derived antimetastatic factor and as a direct cardiac target of aconitine, modulating NO scavenging and ABHD5/AMPK signaling."},"narrative":{"mechanistic_narrative":"HBB encodes the beta subunit of hemoglobin and is the paradigmatic erythroid-specific gene whose expression is controlled by a hierarchy of cis-elements, chromatin architecture, and erythroid transcription factors [PMID:2992937, PMID:14517543]. The promoter requires the TATA box plus a region between -100 and -58 bp for efficient, initiation-site-specific transcription, and as little as 48 bp of 5'-flanking sequence directs correct erythroid-restricted, developmentally timed expression in vivo [PMID:6276753, PMID:2992937]; transcription is strongly stimulated in cis by enhancer elements that function in either orientation over long distances [PMID:6277502], and an erythroid stage-selector element couples the locus enhancer to developmental specificity [PMID:3167976]. Activation is realized through formation of an erythroid-specific active chromatin hub in which the locus control region physically loops to the active globin promoter [PMID:14517543], a configuration that depends on Nipbl-loaded cohesin [PMID:21454523] and on PRMT1-catalyzed H4R3 dimethylation that recruits PCAF to acetylate H3, licensing LCR-promoter looping and transcription-complex recruitment [PMID:20068219]. Developmental gamma-to-beta switching reflects competition of the globin genes for LCR interaction [PMID:1692558] and is governed by the transcription factor EKLF/KLF1, which directly activates beta-globin while indirectly repressing gamma-globin via BCL11A [PMID:8918890, PMID:20676097]; the locus is additionally repressible by sequence-specific binding of nuclear ferritin-H to a -150 CAGTGC motif [PMID:11481480] and is tethered to the nuclear periphery through Suv39H/G9a-mediated H3K9 methylation [PMID:24297746]. Beta-globin pre-mRNA is excised by stepwise splicing in which IVS1 removal generally precedes IVS2 [PMID:7471214, PMID:6292841], and nonsense or splice-site mutations underlie beta-thalassemia: premature termination codons reduce mRNA accumulation at a nuclear/pre-cytoplasmic step characteristic of surveillance [PMID:3353367, PMID:1557399], while intronic mutations such as IVS2-654 create aberrant splice sites that abolish functional beta-globin and recapitulate human disease in mice [PMID:9490703, PMID:30704988]. Beyond erythropoiesis, HBB protein acts as a lung-derived antimetastatic factor through a C-terminal peptide [PMID:27793844] and as a direct cardiac target of aconitine that modulates ABHD5/AMPK signaling and NO scavenging [PMID:38467717].","teleology":[{"year":1982,"claim":"Defining which promoter elements drive beta-globin transcription established the minimal cis-regulatory architecture of the gene.","evidence":"Deletion mutagenesis of the rabbit beta-globin promoter in HeLa cells with S1 nuclease quantitation","pmids":["6276753"],"confidence":"High","gaps":["Did not identify the trans-acting factors binding the -100/-58 element","Tested in non-erythroid HeLa cells, not native erythroid context"]},{"year":1981,"claim":"Demonstrating that an enhancer could stimulate beta-globin transcription ~200-fold in cis, orientation- and distance-independently, defined the enhancer concept for the gene.","evidence":"Transient transfection of beta-globin/SV40 recombinants with S1 nuclease and immunofluorescence readouts","pmids":["6277502"],"confidence":"High","gaps":["Used a heterologous SV40 enhancer rather than the native erythroid enhancer","Mechanism of long-range action not resolved"]},{"year":1981,"claim":"Mapping the co-linear pre-mRNA and the order of intron removal established that beta-globin splicing is stepwise, with IVS1 preceding IVS2.","evidence":"S1 nuclease mapping of endogenous rabbit bone marrow RNA, plus in vitro splicing in HeLa extracts","pmids":["7471214","6292841"],"confidence":"High","gaps":["Spliceosomal components not identified","Determinants of intron order not defined"]},{"year":1985,"claim":"Transgenic expression showed minimal 5'-flanking sequence suffices for erythroid-restricted, developmentally correct beta-globin expression, linking promoter elements to tissue specificity in vivo.","evidence":"Pronuclear microinjection transgenic mice with RNA and erythrocyte protein analysis across 20 lines","pmids":["2992937"],"confidence":"High","gaps":["Did not yet incorporate the LCR for high-level expression","Trans-acting erythroid factors unidentified"]},{"year":1990,"claim":"Establishing that gamma- and beta-globin genes compete for LCR interaction explained the mechanism of developmental switching rather than autonomous gene timing.","evidence":"Transgenic mice with LCR HS fused to single genes versus combined gamma+beta locus fragments","pmids":["1692558"],"confidence":"High","gaps":["Molecular basis of competitive selection not defined","Factors enforcing stage specificity not identified"]},{"year":1996,"claim":"Identifying EKLF/KLF1 as required for beta transcription and for stabilizing LCR-promoter contact placed a specific transcription factor at the center of gamma/beta competition.","evidence":"EKLF knockout / human beta-locus transgenic mice with single-cell transcription and promoter chromatin analysis","pmids":["8918890"],"confidence":"High","gaps":["Downstream effectors of EKLF not resolved at the time","Direct versus indirect repression of gamma not separated"]},{"year":2003,"claim":"Direct measurement of chromatin conformation revealed the active chromatin hub, showing LCR and active globin gene physically cluster, with stage-specific gene contacts.","evidence":"Chromosome conformation capture (3C) with DNase I hypersensitivity across developmental stages in mouse and human","pmids":["14517543"],"confidence":"High","gaps":["Did not identify the proteins driving loop formation","Causality between looping and transcription not yet established"]},{"year":2010,"claim":"Defining PRMT1->H4R3me2->PCAF->H3 acetylation as a requirement for LCR-promoter looping connected a specific histone-modification cascade to chromatin hub formation and transcription.","evidence":"In vitro HAT assay, PCAF Co-IP, PRMT1 knockdown/rescue, ChIP and 3C in MEL erythroid progenitors","pmids":["20068219"],"confidence":"High","gaps":["Recruitment of PRMT1 to the locus not defined","Interplay with other locus-bound factors not mapped"]},{"year":2010,"claim":"Showing KLF1 controls switching through BCL11A clarified that beta activation and gamma repression are partly separable arms of the same factor's program.","evidence":"shRNA KLF1 knockdown in human and mouse adult erythroid progenitors with qRT-PCR of BCL11A and globins","pmids":["20676097"],"confidence":"High","gaps":["Direct KLF1 binding at BCL11A not shown here","Quantitative contribution of direct beta activation versus BCL11A axis unresolved"]},{"year":2011,"claim":"Identifying Nipbl-dependent cohesin binding as required for LCR-gene looping added the architectural machinery underpinning the active chromatin hub.","evidence":"ChIP for cohesin/Nipbl, 3C, and Nipbl siRNA in differentiating MEL and primary erythroid cells","pmids":["21454523"],"confidence":"High","gaps":["How cohesin selects the LCR-promoter contact not defined","Relationship to PRMT1/PCAF cascade not integrated"]},{"year":2001,"claim":"Demonstrating sequence-specific binding and repression by nuclear ferritin-H revealed a negative regulatory input at the beta-globin promoter.","evidence":"EMSA with purified ferritin-H, promoter mutagenesis, and reporter cotransfection with EKLF","pmids":["11481480"],"confidence":"High","gaps":["Physiological conditions triggering ferritin-H repression not defined","Role at the endogenous locus not established"]},{"year":2013,"claim":"Mapping Suv39H/G9a-dependent H3K9 methylation to nuclear peripheral tethering linked locus positioning to specific chromatin marks.","evidence":"BAC transgenesis, FISH, Suv39H/G9a knockdown, and H3K9me2/3 ChIP","pmids":["24297746"],"confidence":"High","gaps":["Functional consequence of peripheral positioning for transcription not resolved","Lamin-association readers not identified"]},{"year":1992,"claim":"Localizing the nonsense-mutation defect to a nuclear/pre-cytoplasmic step distinguished beta-thalassemia mRNA loss from cytoplasmic instability, foreshadowing nuclear surveillance.","evidence":"Transfection into ts-Pol II cells with separate assays of transcription, stability, splicing, and polyadenylation; prior allelic series of five nonsense mutations","pmids":["1557399","3353367"],"confidence":"High","gaps":["Surveillance machinery not molecularly identified in these studies","Position-dependence of the effect not fully resolved"]},{"year":2019,"claim":"Therapeutic CRISPR/Cas12a disruption of aberrant splice sites in patient HSPCs demonstrated that correcting beta-globin splicing restores functional protein, validating splicing mutations as the disease driver.","evidence":"CRISPR RNP electroporation of patient CD34+ HSPCs, erythroid differentiation, splicing RT-PCR and globin HPLC; gene-targeted IVS2-654 mouse model","pmids":["30704988","9490703"],"confidence":"High","gaps":["Long-term engraftment and off-target effects not addressed here","Generalizability across mutation classes not fully tested"]},{"year":2020,"claim":"Showing that reducing beta-globin itself triggers ATF4/MYB/BCL11A-dependent gamma-globin re-expression revealed a feedback stress response coupling beta levels to fetal globin.","evidence":"CRISPR HBB knockout in isogenic erythroid precursors with RNA-seq and ATF4 ChIP at the HBS1L-MYB enhancer","pmids":["32755585"],"confidence":"Medium","gaps":["Single-lab pathway placement","Direct versus indirect ATF4 effects on globins not fully separated"]},{"year":2016,"claim":"Identifying HBB as a lung-derived antimetastatic factor with an active C-terminal peptide established a non-erythroid extracellular function.","evidence":"Peptide mapping of lung factors, in vitro apoptosis assays, and xenograft metastasis models","pmids":["27793844"],"confidence":"Medium","gaps":["Receptor/mechanism of the Metox peptide not defined","Single-lab non-erythroid context"]},{"year":2024,"claim":"Defining HBB as a direct aconitine target that promotes ABHD5/AMPK binding and NO scavenging linked HBB to cardiotoxicity outside its canonical role.","evidence":"Cell-free AC-HBB binding, HBB overexpression/knockdown in cardiomyocytes, Co-IP with ABHD5 and AMPK, S-nitrosylation measurement","pmids":["38467717"],"confidence":"Medium","gaps":["Single-lab Co-IP without reciprocal/structural validation","Physiological relevance beyond aconitine exposure unclear"]},{"year":null,"claim":"How the histone-modification cascade, cohesin architecture, and erythroid transcription factors are mechanistically integrated to nucleate and maintain the active chromatin hub remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["Order of assembly of PRMT1/PCAF, cohesin, and KLF1 at the locus not established","How non-erythroid HBB functions relate to the hemoglobin tetramer not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[14,18,23]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[12,25]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,19,22,24]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[22,25]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[4,5,11,12]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[13,14,23]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[26,27,29]}],"complexes":["active chromatin hub (LCR-beta-globin)"],"partners":["KLF1","BCL11A","PRMT1","PCAF","COHESIN/NIPBL","FERRITIN-H","ABHD5","AMPK"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P68871","full_name":"Hemoglobin subunit beta","aliases":["Beta-globin","Hemoglobin beta chain"],"length_aa":147,"mass_kda":16.0,"function":"Involved in oxygen transport from the lung to the various peripheral tissues LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure Functions as an endogenous inhibitor of enkephalin-degrading enzymes such as DPP3, and as a selective antagonist of the P2RX3 receptor which is involved in pain signaling, these properties implicate it as a regulator of pain and inflammation","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P68871/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HBB","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HBB","total_profiled":1310},"omim":[{"mim_id":"617980","title":"ERYTHROCYTOSIS, FAMILIAL, 6; ECYT6","url":"https://www.omim.org/entry/617980"},{"mim_id":"617971","title":"METHEMOGLOBINEMIA, BETA TYPE","url":"https://www.omim.org/entry/617971"},{"mim_id":"617649","title":"UBIQUITIN-CONJUGATING ENZYME E2 O; UBE2O","url":"https://www.omim.org/entry/617649"},{"mim_id":"614206","title":"CHROMATIN TARGET OF PRMT1; CHTOP","url":"https://www.omim.org/entry/614206"},{"mim_id":"613985","title":"BETA-THALASSEMIA","url":"https://www.omim.org/entry/613985"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":125480.9}],"url":"https://www.proteinatlas.org/search/HBB"},"hgnc":{"alias_symbol":["CD113t-C","beta-globin"],"prev_symbol":[]},"alphafold":{"accession":"P68871","domains":[{"cath_id":"1.10.490.10","chopping":"5-142","consensus_level":"medium","plddt":97.8126,"start":5,"end":142}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P68871","model_url":"https://alphafold.ebi.ac.uk/files/AF-P68871-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P68871-F1-predicted_aligned_error_v6.png","plddt_mean":97.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HBB","jax_strain_url":"https://www.jax.org/strain/search?query=HBB"},"sequence":{"accession":"P68871","fasta_url":"https://rest.uniprot.org/uniprotkb/P68871.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P68871/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P68871"}},"corpus_meta":[{"pmid":"6277502","id":"PMC_6277502","title":"Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.","date":"1981","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6277502","citation_count":1430,"is_preprint":false},{"pmid":"61066","id":"PMC_61066","title":"Amplification and characterization of a beta-globin gene synthesized in vitro.","date":"1976","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/61066","citation_count":449,"is_preprint":false},{"pmid":"14517543","id":"PMC_14517543","title":"The beta-globin nuclear compartment in development and erythroid differentiation.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14517543","citation_count":444,"is_preprint":false},{"pmid":"6097112","id":"PMC_6097112","title":"Nonuniform recombination within the human beta-globin gene cluster.","date":"1984","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6097112","citation_count":428,"is_preprint":false},{"pmid":"2992937","id":"PMC_2992937","title":"Erythroid-specific expression of human beta-globin genes in transgenic mice.","date":"1985","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2992937","citation_count":367,"is_preprint":false},{"pmid":"20676097","id":"PMC_20676097","title":"KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20676097","citation_count":320,"is_preprint":false},{"pmid":"9012826","id":"PMC_9012826","title":"Characterization of the chicken beta-globin insulator.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9012826","citation_count":320,"is_preprint":false},{"pmid":"3167976","id":"PMC_3167976","title":"Developmental regulation of beta-globin gene switching.","date":"1988","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/3167976","citation_count":309,"is_preprint":false},{"pmid":"9334315","id":"PMC_9334315","title":"Intergenic transcription and transinduction of the human beta-globin locus.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9334315","citation_count":289,"is_preprint":false},{"pmid":"1692558","id":"PMC_1692558","title":"Human gamma- to beta-globin gene switching in transgenic mice.","date":"1990","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/1692558","citation_count":263,"is_preprint":false},{"pmid":"6266915","id":"PMC_6266915","title":"Isolation of beta-globin-related genes from a human cosmid library.","date":"1981","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/6266915","citation_count":257,"is_preprint":false},{"pmid":"6276753","id":"PMC_6276753","title":"DNA sequences necessary for transcription of the rabbit beta-globin gene in vivo.","date":"1982","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/6276753","citation_count":256,"is_preprint":false},{"pmid":"3353367","id":"PMC_3353367","title":"Nonsense mutations in the human beta-globin gene affect mRNA metabolism.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3353367","citation_count":249,"is_preprint":false},{"pmid":"6318113","id":"PMC_6318113","title":"Beta-globin gene inactivation by DNA translocation in gamma beta-thalassaemia.","date":"1983","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/6318113","citation_count":229,"is_preprint":false},{"pmid":"6088069","id":"PMC_6088069","title":"DNA sequences required for regulated expression of beta-globin genes in murine erythroleukemia cells.","date":"1984","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6088069","citation_count":192,"is_preprint":false},{"pmid":"291941","id":"PMC_291941","title":"Precise localization of human beta-globin gene complex on chromosome 11.","date":"1979","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/291941","citation_count":183,"is_preprint":false},{"pmid":"8918890","id":"PMC_8918890","title":"The role of EKLF in human beta-globin gene competition.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8918890","citation_count":180,"is_preprint":false},{"pmid":"6572107","id":"PMC_6572107","title":"The regulated expression of beta-globin genes introduced into mouse erythroleukemia cells.","date":"1983","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6572107","citation_count":159,"is_preprint":false},{"pmid":"6946453","id":"PMC_6946453","title":"Transformation of frog embryos with a rabbit beta-globin gene.","date":"1981","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6946453","citation_count":129,"is_preprint":false},{"pmid":"225043","id":"PMC_225043","title":"SV40 recombinants carrying rabbit beta-globin gene coding sequences.","date":"1979","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/225043","citation_count":125,"is_preprint":false},{"pmid":"1557399","id":"PMC_1557399","title":"Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1557399","citation_count":124,"is_preprint":false},{"pmid":"2436649","id":"PMC_2436649","title":"Association of thalassaemia intermedia with a beta-globin gene haplotype.","date":"1987","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/2436649","citation_count":114,"is_preprint":false},{"pmid":"293672","id":"PMC_293672","title":"Introduction and expression of a rabbit beta-globin gene in mouse fibroblasts.","date":"1979","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/293672","citation_count":109,"is_preprint":false},{"pmid":"18282504","id":"PMC_18282504","title":"Beta-globin regulation and long-range interactions.","date":"2008","source":"Advances in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18282504","citation_count":100,"is_preprint":false},{"pmid":"20068219","id":"PMC_20068219","title":"H4R3 methylation facilitates beta-globin transcription by regulating histone acetyltransferase binding and H3 acetylation.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20068219","citation_count":87,"is_preprint":false},{"pmid":"6706976","id":"PMC_6706976","title":"Evolution of the mammalian beta-globin gene cluster.","date":"1984","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6706976","citation_count":87,"is_preprint":false},{"pmid":"24297746","id":"PMC_24297746","title":"β-Globin cis-elements determine differential nuclear targeting through epigenetic modifications.","date":"2013","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24297746","citation_count":85,"is_preprint":false},{"pmid":"11893490","id":"PMC_11893490","title":"ChIPs of the beta-globin locus: unraveling gene regulation within an active domain.","date":"2002","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/11893490","citation_count":82,"is_preprint":false},{"pmid":"21454523","id":"PMC_21454523","title":"Cohesin mediates chromatin interactions that regulate mammalian β-globin expression.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21454523","citation_count":81,"is_preprint":false},{"pmid":"6194893","id":"PMC_6194893","title":"Human beta-globin promoter and coding sequences transcribed by RNA polymerase III.","date":"1983","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6194893","citation_count":79,"is_preprint":false},{"pmid":"9002973","id":"PMC_9002973","title":"Characterization of adult alpha- and beta-globin genes in the zebrafish.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9002973","citation_count":76,"is_preprint":false},{"pmid":"6587773","id":"PMC_6587773","title":"Localization of the beta-globin gene by chromosomal in situ hybridization.","date":"1984","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6587773","citation_count":72,"is_preprint":false},{"pmid":"2236034","id":"PMC_2236034","title":"Beta-globin locus activation regions: conservation of organization, structure, and function.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2236034","citation_count":72,"is_preprint":false},{"pmid":"18767169","id":"PMC_18767169","title":"Joining the loops: beta-globin gene regulation.","date":"2008","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/18767169","citation_count":71,"is_preprint":false},{"pmid":"9490703","id":"PMC_9490703","title":"A common human beta globin splicing mutation modeled in mice.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9490703","citation_count":71,"is_preprint":false},{"pmid":"6292841","id":"PMC_6292841","title":"Accurate in vitro splicing of human beta-globin RNA.","date":"1982","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/6292841","citation_count":68,"is_preprint":false},{"pmid":"8504248","id":"PMC_8504248","title":"Regulation of the beta-globin locus.","date":"1993","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/8504248","citation_count":67,"is_preprint":false},{"pmid":"30704988","id":"PMC_30704988","title":"Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia.","date":"2019","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/30704988","citation_count":65,"is_preprint":false},{"pmid":"2491855","id":"PMC_2491855","title":"Tarsius delta- and beta-globin genes: conversions, evolution, and systematic implications.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2491855","citation_count":62,"is_preprint":false},{"pmid":"6527389","id":"PMC_6527389","title":"The primate psi beta 1 gene. An ancient beta-globin pseudogene.","date":"1984","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/6527389","citation_count":58,"is_preprint":false},{"pmid":"9834248","id":"PMC_9834248","title":"Recombination breakpoints in the human beta-globin gene cluster.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9834248","citation_count":57,"is_preprint":false},{"pmid":"18760288","id":"PMC_18760288","title":"Epigenetics of beta-globin gene regulation.","date":"2008","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/18760288","citation_count":56,"is_preprint":false},{"pmid":"11857746","id":"PMC_11857746","title":"Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.","date":"2002","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11857746","citation_count":52,"is_preprint":false},{"pmid":"7958909","id":"PMC_7958909","title":"Regulated expression of the beta-globin gene locus in synthetic nuclei.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7958909","citation_count":51,"is_preprint":false},{"pmid":"30430274","id":"PMC_30430274","title":"Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors.","date":"2018","source":"Molecular and cellular pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/30430274","citation_count":46,"is_preprint":false},{"pmid":"10931312","id":"PMC_10931312","title":"Site-specific DNA binding and bending by the Borrelia burgdorferi Hbb protein.","date":"2000","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10931312","citation_count":45,"is_preprint":false},{"pmid":"7471214","id":"PMC_7471214","title":"A transcription map for the rabbit beta-globin gene.","date":"1981","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7471214","citation_count":45,"is_preprint":false},{"pmid":"7354859","id":"PMC_7354859","title":"The beta-globin gene is on the short arm of human chromosome 11.","date":"1980","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7354859","citation_count":43,"is_preprint":false},{"pmid":"20563289","id":"PMC_20563289","title":"Brain alpha- and beta-globin expression after intracerebral hemorrhage.","date":"2010","source":"Translational stroke research","url":"https://pubmed.ncbi.nlm.nih.gov/20563289","citation_count":38,"is_preprint":false},{"pmid":"27793844","id":"PMC_27793844","title":"The Beta Subunit of Hemoglobin (HBB2/HBB) Suppresses Neuroblastoma Growth and Metastasis.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27793844","citation_count":38,"is_preprint":false},{"pmid":"11158601","id":"PMC_11158601","title":"An orphaned mammalian beta-globin gene of ancient evolutionary origin.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11158601","citation_count":38,"is_preprint":false},{"pmid":"17283048","id":"PMC_17283048","title":"Beta-globin intergenic transcription and histone acetylation dependent on an enhancer.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17283048","citation_count":37,"is_preprint":false},{"pmid":"32755585","id":"PMC_32755585","title":"ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32755585","citation_count":34,"is_preprint":false},{"pmid":"8101733","id":"PMC_8101733","title":"Beta-thalassemia unlinked to the beta-globin gene in an English family.","date":"1993","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8101733","citation_count":34,"is_preprint":false},{"pmid":"286321","id":"PMC_286321","title":"DNA fragments of the Mus musculus beta globin haplotypes Hbbs and Hbbd.","date":"1979","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/286321","citation_count":32,"is_preprint":false},{"pmid":"28800727","id":"PMC_28800727","title":"A phased SNP-based classification of sickle cell anemia HBB haplotypes.","date":"2017","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/28800727","citation_count":30,"is_preprint":false},{"pmid":"11481480","id":"PMC_11481480","title":"Specific repression of beta-globin promoter activity by nuclear ferritin.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11481480","citation_count":30,"is_preprint":false},{"pmid":"17910027","id":"PMC_17910027","title":"Control of beta globin genes.","date":"2007","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17910027","citation_count":29,"is_preprint":false},{"pmid":"3870874","id":"PMC_3870874","title":"Structure and organization of the bovine beta-globin genes.","date":"1985","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/3870874","citation_count":29,"is_preprint":false},{"pmid":"2835669","id":"PMC_2835669","title":"Role for DNA replication in beta-globin gene activation.","date":"1988","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2835669","citation_count":28,"is_preprint":false},{"pmid":"15009072","id":"PMC_15009072","title":"Thalassaemia mutations within the 5'UTR of the human beta-globin gene disrupt transcription.","date":"2004","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/15009072","citation_count":28,"is_preprint":false},{"pmid":"20395516","id":"PMC_20395516","title":"Comprehensive and efficient HBB mutation analysis for detection of beta-hemoglobinopathies in a pan-ethnic population.","date":"2010","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20395516","citation_count":28,"is_preprint":false},{"pmid":"9973316","id":"PMC_9973316","title":"Oxygen tension modulates beta-globin switching in embryoid bodies.","date":"1999","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/9973316","citation_count":27,"is_preprint":false},{"pmid":"28379995","id":"PMC_28379995","title":"Investigation of mutations in the HBB gene using the 1,000 genomes database.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28379995","citation_count":27,"is_preprint":false},{"pmid":"11012251","id":"PMC_11012251","title":"Gene regulation and deregulation: a beta globin perspective.","date":"2000","source":"Blood reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11012251","citation_count":25,"is_preprint":false},{"pmid":"6096121","id":"PMC_6096121","title":"Modular structure of the beta-globin and the TK promoters.","date":"1984","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6096121","citation_count":24,"is_preprint":false},{"pmid":"29637841","id":"PMC_29637841","title":"Geographical distribution of β-globin gene mutations in Syria.","date":"2018","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/29637841","citation_count":22,"is_preprint":false},{"pmid":"1661900","id":"PMC_1661900","title":"Variability in beta-globin and HPV DNA amplification by PCR from fixed tissues.","date":"1991","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/1661900","citation_count":22,"is_preprint":false},{"pmid":"15881896","id":"PMC_15881896","title":"Developmental regulation of the beta-globin gene locus.","date":"2005","source":"Progress in molecular and subcellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15881896","citation_count":21,"is_preprint":false},{"pmid":"12409448","id":"PMC_12409448","title":"Temperature-dependent splicing of beta-globin pre-mRNA.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12409448","citation_count":21,"is_preprint":false},{"pmid":"38155279","id":"PMC_38155279","title":"Targeting lncRNA16 by GalNAc-siRNA conjugates facilitates chemotherapeutic sensibilization via the HBB/NDUFAF5/ROS pathway.","date":"2023","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38155279","citation_count":18,"is_preprint":false},{"pmid":"12126952","id":"PMC_12126952","title":"Chromatin structure and transcriptional regulation of the beta-globin locus.","date":"2002","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12126952","citation_count":17,"is_preprint":false},{"pmid":"20451566","id":"PMC_20451566","title":"Evaluation of real-time PCR targeting hbb gene for Borrelia species identification.","date":"2010","source":"Journal of microbiological methods","url":"https://pubmed.ncbi.nlm.nih.gov/20451566","citation_count":17,"is_preprint":false},{"pmid":"22374078","id":"PMC_22374078","title":"Epigenetic modifications and chromosome conformations of the beta globin locus throughout development.","date":"2013","source":"Stem cell reviews and reports","url":"https://pubmed.ncbi.nlm.nih.gov/22374078","citation_count":17,"is_preprint":false},{"pmid":"19440680","id":"PMC_19440680","title":"Clinical and hematological characteristics of uncommon beta-globin variants in Thailand.","date":"2009","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/19440680","citation_count":17,"is_preprint":false},{"pmid":"3828304","id":"PMC_3828304","title":"Selective solubilization of beta-globin oligonucleosomes at low ionic strength.","date":"1987","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3828304","citation_count":17,"is_preprint":false},{"pmid":"29626925","id":"PMC_29626925","title":"Genetic and Epigenetic Mechanisms of β-Globin Gene Switching.","date":"2018","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/29626925","citation_count":16,"is_preprint":false},{"pmid":"24099628","id":"PMC_24099628","title":"Distinctive mutation spectrum of the HBB gene in an urban eastern Indian population.","date":"2013","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/24099628","citation_count":16,"is_preprint":false},{"pmid":"28161275","id":"PMC_28161275","title":"Epigenetic interplay at the β-globin locus.","date":"2017","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/28161275","citation_count":14,"is_preprint":false},{"pmid":"15358579","id":"PMC_15358579","title":"The mammalian beta globin origin of DNA replication.","date":"2004","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/15358579","citation_count":14,"is_preprint":false},{"pmid":"38864377","id":"PMC_38864377","title":"Bacterial histone HBb from Bdellovibrio bacteriovorus compacts DNA by bending.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38864377","citation_count":14,"is_preprint":false},{"pmid":"20466031","id":"PMC_20466031","title":"Structural polymorphism at LCR and its role in beta-globin gene regulation.","date":"2010","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/20466031","citation_count":14,"is_preprint":false},{"pmid":"25617386","id":"PMC_25617386","title":"β-Globin Mutations in Egyptian Patients With β-Thalassemia.","date":"2015","source":"Laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25617386","citation_count":14,"is_preprint":false},{"pmid":"20406103","id":"PMC_20406103","title":"Mutation analysis of the HBB gene in selected Bangladeshi beta-thalassemic individuals: presence of rare mutations.","date":"2010","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/20406103","citation_count":14,"is_preprint":false},{"pmid":"32674615","id":"PMC_32674615","title":"Hematological Characteristics of β-Globin Gene Mutation -50 (G>A) (HBB: c.-100G>A) Carriers in Mainland China.","date":"2020","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/32674615","citation_count":13,"is_preprint":false},{"pmid":"8756085","id":"PMC_8756085","title":"Beta-globin gene haplotype in Hb SC disease.","date":"1996","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/8756085","citation_count":13,"is_preprint":false},{"pmid":"25523871","id":"PMC_25523871","title":"β-globin genes: mutation hot-spots in the global thalassemia belt.","date":"2014","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/25523871","citation_count":12,"is_preprint":false},{"pmid":"23497547","id":"PMC_23497547","title":"Relationship between beta-globin gene carrier state and insulin resistance.","date":"2012","source":"Journal of diabetes and metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/23497547","citation_count":11,"is_preprint":false},{"pmid":"18404216","id":"PMC_18404216","title":"Beta-globin LCR and intron elements cooperate and direct spatial reorganization for gene therapy.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18404216","citation_count":11,"is_preprint":false},{"pmid":"2228698","id":"PMC_2228698","title":"Beta-globin gene cluster haplotypes in Hb C heterozygotes.","date":"1990","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/2228698","citation_count":11,"is_preprint":false},{"pmid":"15018035","id":"PMC_15018035","title":"Beta-globin gene cluster haplotypes in the Corsican and Sardinian populations.","date":"2003","source":"Human biology","url":"https://pubmed.ncbi.nlm.nih.gov/15018035","citation_count":11,"is_preprint":false},{"pmid":"3120465","id":"PMC_3120465","title":"The origin of mutant beta-globin genes in human populations.","date":"1987","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/3120465","citation_count":10,"is_preprint":false},{"pmid":"27050243","id":"PMC_27050243","title":"Total Hemoglobin Mass, Aerobic Capacity, and HBB Gene in Polish Road Cyclists.","date":"2016","source":"Journal of strength and conditioning research","url":"https://pubmed.ncbi.nlm.nih.gov/27050243","citation_count":10,"is_preprint":false},{"pmid":"38467717","id":"PMC_38467717","title":"HBB contributes to individualized aconitine-induced cardiotoxicity in mice via interfering with ABHD5/AMPK/HDAC4 axis.","date":"2024","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/38467717","citation_count":10,"is_preprint":false},{"pmid":"7499351","id":"PMC_7499351","title":"Nuclear factor binding sites in human beta globin IVS2.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7499351","citation_count":10,"is_preprint":false},{"pmid":"3459181","id":"PMC_3459181","title":"A naturally occurring deletion in the mouse Hbbs beta-globin gene cluster.","date":"1986","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3459181","citation_count":10,"is_preprint":false},{"pmid":"31394941","id":"PMC_31394941","title":"Unusual β-Globin Haplotype Distribution in Newborns from Bengo, Angola.","date":"2019","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/31394941","citation_count":9,"is_preprint":false},{"pmid":"23056075","id":"PMC_23056075","title":"β-Globin chain abnormalities with coexisting α-thalassemia mutations.","date":"2012","source":"Archives of medical science : AMS","url":"https://pubmed.ncbi.nlm.nih.gov/23056075","citation_count":9,"is_preprint":false},{"pmid":"9071021","id":"PMC_9071021","title":"A gene tree for beta-globin sequences from Melanesia.","date":"1997","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/9071021","citation_count":9,"is_preprint":false},{"pmid":"31987908","id":"PMC_31987908","title":"Development of gene editing strategies for human β-globin (HBB) gene mutations.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31987908","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":39380,"output_tokens":8684,"usd":0.1242,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18590,"output_tokens":5078,"usd":0.10995,"stage2_stop_reason":"end_turn"},"total_usd":0.23415,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1981,\n      \"finding\": \"A 72-bp repeated sequence element in SV40 DNA (transcriptional enhancer) acts in cis to increase beta-globin gene transcription ~200-fold; the element functions in either orientation and at positions up to 1400 bp upstream or 3300 bp downstream of the beta-globin transcription initiation site.\",\n      \"method\": \"Transient transfection of HeLa cells with beta-globin gene-SV40 recombinant plasmids; S1 nuclease hybridization assay; immunofluorescent staining for beta-globin protein\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in transfected cells with systematic deletion/orientation mutants, multiple orthogonal readouts (RNA and protein), foundational enhancer study\",\n      \"pmids\": [\"6277502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1982,\n      \"finding\": \"Efficient transcription of the rabbit beta-globin gene in vivo requires both the ATA (TATA) box and a region between -100 and -58 bp upstream of the transcription start site; deletion of either region reduces transcript levels ~10-fold, and deletion of the ATA box also abolishes initiation-site specificity. Sequences downstream of the ATA box, including the natural cap site, are dispensable.\",\n      \"method\": \"Deletion mutagenesis of the rabbit beta-globin gene introduced into HeLa cells via SV40-plasmid recombinants; S1 nuclease quantitation of beta-globin transcripts\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic promoter deletion mutagenesis with quantitative RNA readout, multiple mutants tested\",\n      \"pmids\": [\"6276753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"An SV40-globin hybrid transcript is produced and translated in infected monkey cells only when the construct retains a ~500 bp SV40 RNA splicing region; deletion of this splicing region abolishes stable globin transcript accumulation and beta-globin protein production.\",\n      \"method\": \"Construction of SV40-beta-globin recombinant viruses with defined deletions; radioimmunoassay for beta-globin protein; RNA analysis in infected monkey cells\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — deletion mutagenesis and protein detection, single lab study\",\n      \"pmids\": [\"225043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1981,\n      \"finding\": \"The rabbit beta-globin promoter is recognized and transcripts are correctly spliced when the gene is expressed in Xenopus laevis frog embryos, demonstrating conservation of the basic transcriptional and splicing machinery across vertebrates.\",\n      \"method\": \"Microinjection of rabbit beta-globin gene into fertilized Xenopus eggs; S1 nuclease mapping of transcripts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo expression assay with RNA-level verification, single lab\",\n      \"pmids\": [\"6946453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1981,\n      \"finding\": \"The largest beta-globin pre-mRNA is co-linear with the gene and contains both intervening sequences; splicing proceeds stepwise, with removal of the small intron (IVS1) generally preceding removal of the large intron (IVS2), generating partially spliced intermediates.\",\n      \"method\": \"S1 nuclease mapping of RNA from rabbit bone marrow\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct S1 mapping of endogenous bone marrow RNA with multiple partially spliced intermediates characterized\",\n      \"pmids\": [\"7471214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1982,\n      \"finding\": \"Human beta-globin pre-mRNA is accurately spliced in vitro by HeLa cell whole-cell extracts; the small intervening sequence is removed precisely, yielding a junction sequence identical to authentic reticulocyte beta-globin mRNA. A transcript terminated upstream of the polyadenylation site is spliced most efficiently, whereas one terminated downstream is not spliced.\",\n      \"method\": \"In vitro splicing assay with HeLa cell extracts; primer extension analysis of splice junctions\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution in vitro with sequence verification of splice junction\",\n      \"pmids\": [\"6292841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"The human beta-globin promoter and coding sequences are transcribed by RNA polymerase III (in addition to Pol II); these Pol III transcripts are polyadenylated, probably spliced, and detectable in bone marrow and reticulocytes. Their 5' boundaries map near an Alu-related Pol III promoter consensus sequence between -235 and the cap site.\",\n      \"method\": \"In vitro transcription with alpha-amanitin sensitivity assay; in vivo RNA analysis in bone marrow and reticulocytes\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition plus in vitro and in vivo RNA detection, single lab\",\n      \"pmids\": [\"6194893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"Induction of beta-globin gene expression in murine erythroleukemia (MEL) cells requires DNA sequences both 5' and 3' of the translation initiation site; hybrid gene experiments show that the 3' beta-globin sequences (coding region) are sufficient to confer inducibility on heterologous promoters, and nuclear run-on confirms induction is at least partly transcriptional.\",\n      \"method\": \"Introduction of deletion mutants and hybrid genes (beta/gamma, beta/H-2Kbm1) into MEL cells; S1 nuclease analysis before and after differentiation; nuclear run-on transcription assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis in differentiation model with nuclear run-on, multiple constructs tested\",\n      \"pmids\": [\"6088069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"Induction of the beta-globin gene during MEL cell differentiation results at least in part from increased transcription rate, as shown by nuclear transcription (run-on) experiments; both the intact human beta-globin gene and a hybrid mouse-human beta-globin gene are inducible, indicating the regulatory sequences are conserved between mouse and human.\",\n      \"method\": \"Stable cotransformation of MEL cells; S1 nuclease and primer extension analysis; nuclear transcription run-on experiments\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — nuclear run-on transcription assay plus mRNA analysis with multiple constructs, single lab\",\n      \"pmids\": [\"6572107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1985,\n      \"finding\": \"Human beta-globin gene expression in transgenic mice is restricted to erythroid lineage cells; constructs with as little as 48 bp of 5'-flanking sequence drive erythroid-specific, temporally correct expression. mRNA transcripts have correct 5' ends and direct beta-globin protein synthesis, and human beta-globin protein is detectable in mature erythrocytes.\",\n      \"method\": \"Pronuclear microinjection to generate transgenic mice; S1 nuclease/primer extension for RNA analysis; reticulocyte lysate translation; protein detection in erythrocytes\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic model with RNA and protein readouts, multiple constructs, replicated across 20 transgenic lines\",\n      \"pmids\": [\"2992937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"A chicken erythroid cell-specific enhancer in the intergenic region between adult beta- and embryonic epsilon-globin genes activates transcription of both; correct developmental stage-specific regulation of beta-globin requires interaction of the beta-globin enhancer with a positive regulatory element (the developmental stage selector element, SSE) within the adult beta-globin promoter.\",\n      \"method\": \"Deletion and substitution mutant analysis in avian erythroid cells; transient transfection assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic promoter and enhancer mutagenesis with functional readout in erythroid cells, multiple mutants\",\n      \"pmids\": [\"3167976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Premature translation termination (nonsense) mutations in the human beta-globin gene decrease steady-state mRNA levels; this effect is observed for all five nonsense mutations tested (at codons 15, 17, 26, 39, 112) but not for two missense mutations, indicating that the presence of a stop codon per se—regardless of position or type—correlates with reduced mRNA accumulation.\",\n      \"method\": \"Heterologous transfection of cloned beta-globin genes carrying defined point mutations; steady-state mRNA quantitation by S1 nuclease assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple allelic series tested in parallel transfection system, replicated across five nonsense and two missense mutations\",\n      \"pmids\": [\"3353367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The beta-39 nonsense mutation reduces beta-globin mRNA accumulation at a step prior to cytoplasmic accumulation (i.e., a nuclear/pre-cytoplasmic step); cytoplasmic mRNA stability, splicing accuracy, and polyadenylation are not affected, pointing to a defect in nuclear mRNA metabolism.\",\n      \"method\": \"Transfection into cell lines carrying temperature-sensitive RNA Pol II; analysis of transcription rate, mRNA stability, splicing accuracy, and polyadenylation separately\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal RNA metabolism steps assayed in a single well-controlled study with ts-Pol II cells\",\n      \"pmids\": [\"1557399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Human gamma-to-beta globin switching in transgenic mice is restored when both gamma- and beta-globin genes compete together for interaction with the LCR hypersensitive (HS) sequences; when HS sequences are fused individually to either gene alone, high expression is achieved but temporal specificity is lost, demonstrating that developmental switching results from gene competition for LCR interaction.\",\n      \"method\": \"Transgenic mice with LCR HS sequences fused to individual globin genes or combined gamma+beta locus fragments; developmental expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic competition assay with multiple construct comparisons, mechanistic epistasis established\",\n      \"pmids\": [\"1692558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"EKLF (erythroid Krüppel-like factor) is required for beta-globin gene transcription and for stabilizing LCR-beta-globin promoter interaction; in EKLF knockout mice the beta-globin promoter chromatin structure is altered, beta-gene transcription is absent, and gamma-gene transcription increases reciprocally. This demonstrates EKLF plays a major role in gamma/beta competition.\",\n      \"method\": \"Compound EKLF knockout / human beta-locus transgenic mice; single-cell transcription analysis; chromatin structure analysis at beta-globin promoter\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in vivo with chromatin structure readout, multiple genotypes compared\",\n      \"pmids\": [\"8918890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"DNA replication is required for transcriptional activation of the Xenopus beta-globin gene in HeLa cell transfections; replication does not act through covalent template modification or simply by increasing copy number, and only replicating templates are transcribed even when co-transfected with non-replicating templates, indicating a direct mechanistic role for replication in gene activation.\",\n      \"method\": \"Transfection of replicating vs. non-replicating Xenopus beta-globin constructs in HeLa cells; co-transfection experiments; copy number analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — controlled co-transfection design with multiple mechanistic controls, single lab\",\n      \"pmids\": [\"2835669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Assembly of the chick beta-globin gene locus into synthetic nuclei using Xenopus egg extracts in an erythroid protein environment recapitulates tissue-specific chromatin structure and long-range promoter-enhancer interaction, leading to beta-globin gene activation; nucleosome-repressed templates can be reactivated by DNA replication in the presence of staged erythroid proteins via chromatin remodeling at the promoter and re-establishment of distal enhancer-promoter communication.\",\n      \"method\": \"Synthetic nuclei reconstitution using Xenopus egg extracts; chromatin assembly; transcription assays with erythroid vs. non-erythroid protein extracts\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution with chromatin assembly and functional transcription readout, demonstrates promoter-enhancer communication mechanistically\",\n      \"pmids\": [\"7958909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Novel intergenic nuclear transcripts span the LCR and intergenic regions of the human beta-globin locus in erythroid cells; transient transfection of a beta-globin gene (epsilon, gamma, or beta) induces transcription of the chromosomal LCR and intergenic regions in nonerythroid cells (transinduction) by a mechanism requiring transcription of the plasmid but not protein expression. The plasmid co-localizes with the endogenous locus as shown by in situ hybridization.\",\n      \"method\": \"Nuclear run-on transcription analysis; transient transfection; fluorescence in situ hybridization (FISH) for co-localization\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — nuclear run-on plus FISH co-localization, single lab, mechanistic novelty\",\n      \"pmids\": [\"9334315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Nuclear ferritin-H specifically binds the CAGTGC motif at position -153 to -148 bp of the human beta-globin promoter; mutation of this motif reduces binding 20-fold in competition gel-shift assays and abolishes ferritin-H-mediated repression of beta-globin promoter-driven reporter expression in cotransfected cells, demonstrating ferritin-H functions as a sequence-specific repressor of the beta-globin gene.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA)/competition gel-shift with K562 nuclear extracts and purified human ferritin-H; site-directed mutagenesis of promoter; reporter gene cotransfection with EKLF and ferritin-H expression vectors in CV-1 cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — DNA-binding assay with purified protein plus mutagenesis of binding site linked to functional reporter assay, two orthogonal methods\",\n      \"pmids\": [\"11481480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"An erythroid-specific spatial cluster of cis-regulatory elements (active chromatin hub, ACH) forms around the beta-globin LCR and the active globin gene; the core ACH (HS1-HS6 plus upstream 5'HS-60/-62 and downstream 3'HS1) is developmentally conserved in mice and humans. Individual globin genes switch their physical interaction with this cluster during development correlating with changes in their transcriptional activity; in committed erythroid progenitors prior to beta-globin expression only LCR 5'-side interactions are stably present.\",\n      \"method\": \"Chromosome conformation capture (3C); DNase I hypersensitivity; developmental stage analysis in mouse and human erythroid cells\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — 3C chromatin interaction mapping across multiple developmental stages in two species, replicated\",\n      \"pmids\": [\"14517543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Thalassemia mutations in the 5'UTR of the human beta-globin gene (+10(-T), +22(G>A), +33(C>G), +(40-43)(-AAAC)) reduce steady-state mRNA levels 15-38%; nuclear run-on experiments show that +10(-T) and +33(C>G) reduce the transcription rate (disrupting downstream promoter sequences), while +22(G>A) primarily acts post-transcriptionally; none affect mRNA transport, 3' end processing, or cytoplasmic stability.\",\n      \"method\": \"Stable transfection in MEL cells under LCR control; S1 nuclease/RNA quantitation; nuclear run-on; RNA stability assays; nuclear/cytoplasmic fractionation\",\n      \"journal\": \"British journal of haematology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal RNA metabolism assays with allelic series in stable chromatin context\",\n      \"pmids\": [\"15009072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"An intact HS2 enhancer that recruits RNA Pol II is required for intergenic transcription and histone H3 acetylation and H3K4 methylation between the enhancer and the epsilon-globin target gene; however, intergenic transcription and histone modifications are not sufficient for target gene transcription, which additionally requires initiation at the TATA box of the target gene—indicating intergenic and genic transcription complexes are independent.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for H3 acetylation and H3K4 methylation; model locus with HS2-epsilon-globin in chromatin; enhancer deletion analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with enhancer deletion in chromatin model, mechanistically dissects intergenic vs. genic transcription\",\n      \"pmids\": [\"17283048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PRMT1-catalyzed asymmetric dimethylation of H4R3 at the beta-globin locus directly enhances histone H3 acetylation (Lys9/Lys14) in vitro by providing a binding surface for PCAF; these modifications are required for efficient LCR-beta-promoter looping, transcription complex recruitment, and beta-globin transcription. PRMT1 knockdown prevents H3 acetylation, LCR-promoter interaction, and erythroid differentiation, all rescued by re-introduction of PRMT1.\",\n      \"method\": \"In vitro histone acetyltransferase assay with dimethyl-H4R3 substrate; co-immunoprecipitation of PCAF with modified H4R3; shRNA knockdown of PRMT1 in MEL erythroid progenitors; ChIP; 3C for LCR-promoter interaction; rescue experiment with rat PRMT1\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical assay plus mutagenesis context, knockdown/rescue, ChIP, and 3C chromatin looping assay, multiple orthogonal methods\",\n      \"pmids\": [\"20068219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"KLF1 knockdown in human and mouse adult erythroid progenitors markedly reduces BCL11A expression and increases gamma-globin/beta-globin expression ratios, indicating KLF1 controls globin switching by directly activating beta-globin and indirectly repressing gamma-globin through BCL11A.\",\n      \"method\": \"shRNA knockdown of KLF1 in human and mouse adult erythroid progenitors; quantitative RT-PCR for BCL11A, gamma-globin, and beta-globin\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function in two species with defined molecular pathway placement (KLF1→BCL11A→gamma/beta ratio)\",\n      \"pmids\": [\"20676097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Upon erythroid differentiation, cohesin and its loading factor Nipbl bind the beta-globin LCR and the activated globin gene; Nipbl-dependent cohesin binding is required for long-range chromatin interactions between CTCF insulator elements and between the LCR distal enhancer and the target globin gene, the latter being critical for globin gene expression in vivo and in vitro.\",\n      \"method\": \"ChIP for cohesin and Nipbl occupancy; chromosome conformation capture (3C); siRNA knockdown of Nipbl; analysis in differentiating MEL and primary erythroid cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, 3C, and RNAi knockdown with functional gene expression readout, multiple complementary methods\",\n      \"pmids\": [\"21454523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Three peripheral targeting regions (PTRs) in the HBB BAC drive nuclear peripheral localization of the beta-globin locus; targeting to both peripheral and pericentric heterochromatin depends on Suv39H-mediated H3K9me3 methylation across hundreds of kilobases around HBB, and peripheral tethering of the endogenous HBB locus additionally requires G9a-mediated H3K9me2 in flanking lamin-associated domains.\",\n      \"method\": \"BAC transgenesis; FISH; siRNA knockdown of Suv39H and G9a; chromatin fractionation; ChIP for H3K9me2/3\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — BAC transgene + endogenous locus analysis + knockdown + FISH + ChIP, multiple orthogonal methods in single study\",\n      \"pmids\": [\"24297746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Replacement of the murine beta-globin genes with the human betaIVS-2-654 C>T thalassemic gene by gene targeting shows that this mutation causes the same aberrant RNA splicing in mice as in humans; no homozygous mice survive postnatally, and heterozygotes show reduced mouse beta-globin, no human beta-globin, and moderate beta-thalassemia.\",\n      \"method\": \"Homologous recombination gene targeting in mouse embryonic stem cells ('plug and socket' method); RNA splicing analysis; hematological characterization of heterozygous mice\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — precise gene targeting in vivo with splicing analysis and hematological phenotype, replicates human disease mechanism\",\n      \"pmids\": [\"9490703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A T>G mutation at nucleotide 705 of human beta-globin intron 2 creates an aberrant 5' splice site that dominates over the correct splice sites; at temperatures below 30°C this aberrant splicing is inhibited and correct splicing is restored, demonstrating that temperature is a parameter affecting splice site selection in this thalassemic context.\",\n      \"method\": \"Stable cell lines (HeLa, K562) carrying IVS2-705 or IVS2-745 beta-globin constructs; culture at varying temperatures; RT-PCR analysis of splicing products\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined mutation in stable cell lines, temperature-dose response, single lab\",\n      \"pmids\": [\"12409448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The second intron (IVS2) of the human beta-globin gene contains four GATA-1 binding sites, two Oct-1 binding sites, two SATB1 binding sites, and a potential homeobox protein binding site, as identified by DNase I footprinting and EMSA of the entire IVS2.\",\n      \"method\": \"DNase I footprinting of entire beta-globin IVS2; electrophoretic mobility shift assay (EMSA); antibody supershift for GATA-1, NFE-2, YY1, Oct-1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — comprehensive footprinting and EMSA across entire intron, single lab, binding sites identified but functional role inferred\",\n      \"pmids\": [\"7499351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRISPR/Cas9 (targeting IVS1-110G>A mutation) and Cas12a/Cpf1 (targeting IVS2-654C>T mutation) RNP complexes achieve high-efficiency disruption of aberrant splice sites in primary CD34+ HSPCs from beta-thalassemia patients; erythroid progeny of edited cells show reversal of aberrant splicing and restoration of beta-globin expression.\",\n      \"method\": \"CRISPR RNP electroporation into primary CD34+ HSPCs; erythroid differentiation; RT-PCR for splicing; globin chain HPLC for beta-globin protein restoration\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — therapeutic editing in primary human HSPCs with functional protein readout, two distinct mutations and nucleases tested\",\n      \"pmids\": [\"30704988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CRISPR-Cas9-mediated reduction of beta-globin in differentiating erythroid precursors is sufficient to induce robust re-expression of gamma-globin; RNA-seq identifies ATF4 as a causal regulator of this stress response—ATF4 binds the HBS1L-MYB intergenic enhancer and regulates MYB, which in turn controls BCL11A and gamma-globin levels.\",\n      \"method\": \"CRISPR-Cas9 knockout of HBB in isogenic erythroid precursors; RNA-seq; ATF4 ChIP at HBS1L-MYB enhancer; quantitation of MYB, BCL11A, and globin expression\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic CRISPR model plus ChIP for ATF4 binding, single lab, pathway placement via RNA-seq and ChIP\",\n      \"pmids\": [\"32755585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HBB (hemoglobin subunit beta) is a direct molecular target of aconitine (AC) in cell-free hemoglobin; AC binding to HBB enhances HBB-ABHD5 and HBB-AMPK binding, leading to decreased HDAC-NT generation and cardiomyocyte death. HBB overexpression exacerbates AC-induced cardiotoxicity while HBB knockdown attenuates cardiomyocyte death. AC-triggered hemolysis releases HBB which scavenges NO, decreasing cardioprotective S-nitrosylation.\",\n      \"method\": \"RNA-seq in DO mice; HBB overexpression and knockdown in cardiomyocytes; cell-free binding assay for AC-HBB interaction; co-immunoprecipitation of HBB with ABHD5 and AMPK; measurement of S-nitrosylation and HDAC-NT\",\n      \"journal\": \"Acta pharmacologica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression/knockdown with protein interaction data (Co-IP) and functional readout, single lab\",\n      \"pmids\": [\"38467717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The beta subunit of hemoglobin (HBB) acts as a lung-derived antimetastatic factor; a short C-terminal peptide region (Metox) is responsible for activity. HBB and the Metox peptide mediate growth arrest and apoptosis of neuroblastoma and other cancer cell lines in vitro, and Metox administration in xenograft models limits adrenal tumor development and spontaneous lung and bone marrow metastases. HBB2 is produced by alveolar epithelial and endothelial cells and is upregulated in mice bearing undetectable metastases.\",\n      \"method\": \"Peptide mapping/fractionation of lung-derived soluble factors; in vitro viability/apoptosis assays; xenograft mouse models; IHC/expression studies for cellular source\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — peptide mapping plus in vitro and in vivo functional assays, single lab, non-erythroid context\",\n      \"pmids\": [\"27793844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HBB (beta-globin) mRNA and protein are expressed in neurons of the brain and are increased in the perihematomal zone after intracerebral hemorrhage; hemin upregulates HBB mRNA in cultured neurons, and this is reduced by the iron chelator deferoxamine, indicating a role for iron/heme signaling in neuronal HBB regulation.\",\n      \"method\": \"In vivo ICH rat model with time-course; in vitro cultured neurons exposed to hemin ± deferoxamine; qRT-PCR and Western blot; immunolocalization\",\n      \"journal\": \"Translational stroke research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — expression and localization data with pharmacological manipulation, single lab, no direct mechanistic pathway established\",\n      \"pmids\": [\"20563289\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HBB (beta-globin) is transcriptionally activated in erythroid cells through a hierarchical mechanism in which the locus control region (LCR) physically loops to contact the active beta-globin promoter (active chromatin hub), a process mediated by cohesin/Nipbl binding, PRMT1-catalyzed H4R3 dimethylation that recruits PCAF for H3 acetylation, and the transcription factor KLF1 (which directly activates beta-globin and indirectly represses gamma-globin via BCL11A); promoter activity requires the TATA box and a −100 to −58 bp upstream element, and is repressible by nuclear ferritin-H binding a −150 CAGTGC motif; beta-globin pre-mRNA is processed by stepwise splicing (IVS1 before IVS2) and nonsense mutations reduce mRNA accumulation at a nuclear pre-cytoplasmic step via NMD-like surveillance; peripheral nuclear positioning of the HBB locus depends on Suv39H/G9a-mediated H3K9 methylation; and outside erythroid cells, HBB protein functions as a lung-derived antimetastatic factor and as a direct cardiac target of aconitine, modulating NO scavenging and ABHD5/AMPK signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HBB encodes the beta subunit of hemoglobin and is the paradigmatic erythroid-specific gene whose expression is controlled by a hierarchy of cis-elements, chromatin architecture, and erythroid transcription factors [#9, #19]. The promoter requires the TATA box plus a region between -100 and -58 bp for efficient, initiation-site-specific transcription, and as little as 48 bp of 5'-flanking sequence directs correct erythroid-restricted, developmentally timed expression in vivo [#1, #9]; transcription is strongly stimulated in cis by enhancer elements that function in either orientation over long distances [#0], and an erythroid stage-selector element couples the locus enhancer to developmental specificity [#10]. Activation is realized through formation of an erythroid-specific active chromatin hub in which the locus control region physically loops to the active globin promoter [#19], a configuration that depends on Nipbl-loaded cohesin [#24] and on PRMT1-catalyzed H4R3 dimethylation that recruits PCAF to acetylate H3, licensing LCR-promoter looping and transcription-complex recruitment [#22]. Developmental gamma-to-beta switching reflects competition of the globin genes for LCR interaction [#13] and is governed by the transcription factor EKLF/KLF1, which directly activates beta-globin while indirectly repressing gamma-globin via BCL11A [#14, #23]; the locus is additionally repressible by sequence-specific binding of nuclear ferritin-H to a -150 CAGTGC motif [#18] and is tethered to the nuclear periphery through Suv39H/G9a-mediated H3K9 methylation [#25]. Beta-globin pre-mRNA is excised by stepwise splicing in which IVS1 removal generally precedes IVS2 [#4, #5], and nonsense or splice-site mutations underlie beta-thalassemia: premature termination codons reduce mRNA accumulation at a nuclear/pre-cytoplasmic step characteristic of surveillance [#11, #12], while intronic mutations such as IVS2-654 create aberrant splice sites that abolish functional beta-globin and recapitulate human disease in mice [#26, #29]. Beyond erythropoiesis, HBB protein acts as a lung-derived antimetastatic factor through a C-terminal peptide [#32] and as a direct cardiac target of aconitine that modulates ABHD5/AMPK signaling and NO scavenging [#31].\",\n  \"teleology\": [\n    {\n      \"year\": 1982,\n      \"claim\": \"Defining which promoter elements drive beta-globin transcription established the minimal cis-regulatory architecture of the gene.\",\n      \"evidence\": \"Deletion mutagenesis of the rabbit beta-globin promoter in HeLa cells with S1 nuclease quantitation\",\n      \"pmids\": [\"6276753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the trans-acting factors binding the -100/-58 element\", \"Tested in non-erythroid HeLa cells, not native erythroid context\"]\n    },\n    {\n      \"year\": 1981,\n      \"claim\": \"Demonstrating that an enhancer could stimulate beta-globin transcription ~200-fold in cis, orientation- and distance-independently, defined the enhancer concept for the gene.\",\n      \"evidence\": \"Transient transfection of beta-globin/SV40 recombinants with S1 nuclease and immunofluorescence readouts\",\n      \"pmids\": [\"6277502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Used a heterologous SV40 enhancer rather than the native erythroid enhancer\", \"Mechanism of long-range action not resolved\"]\n    },\n    {\n      \"year\": 1981,\n      \"claim\": \"Mapping the co-linear pre-mRNA and the order of intron removal established that beta-globin splicing is stepwise, with IVS1 preceding IVS2.\",\n      \"evidence\": \"S1 nuclease mapping of endogenous rabbit bone marrow RNA, plus in vitro splicing in HeLa extracts\",\n      \"pmids\": [\"7471214\", \"6292841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spliceosomal components not identified\", \"Determinants of intron order not defined\"]\n    },\n    {\n      \"year\": 1985,\n      \"claim\": \"Transgenic expression showed minimal 5'-flanking sequence suffices for erythroid-restricted, developmentally correct beta-globin expression, linking promoter elements to tissue specificity in vivo.\",\n      \"evidence\": \"Pronuclear microinjection transgenic mice with RNA and erythrocyte protein analysis across 20 lines\",\n      \"pmids\": [\"2992937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not yet incorporate the LCR for high-level expression\", \"Trans-acting erythroid factors unidentified\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing that gamma- and beta-globin genes compete for LCR interaction explained the mechanism of developmental switching rather than autonomous gene timing.\",\n      \"evidence\": \"Transgenic mice with LCR HS fused to single genes versus combined gamma+beta locus fragments\",\n      \"pmids\": [\"1692558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of competitive selection not defined\", \"Factors enforcing stage specificity not identified\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identifying EKLF/KLF1 as required for beta transcription and for stabilizing LCR-promoter contact placed a specific transcription factor at the center of gamma/beta competition.\",\n      \"evidence\": \"EKLF knockout / human beta-locus transgenic mice with single-cell transcription and promoter chromatin analysis\",\n      \"pmids\": [\"8918890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of EKLF not resolved at the time\", \"Direct versus indirect repression of gamma not separated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Direct measurement of chromatin conformation revealed the active chromatin hub, showing LCR and active globin gene physically cluster, with stage-specific gene contacts.\",\n      \"evidence\": \"Chromosome conformation capture (3C) with DNase I hypersensitivity across developmental stages in mouse and human\",\n      \"pmids\": [\"14517543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the proteins driving loop formation\", \"Causality between looping and transcription not yet established\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining PRMT1->H4R3me2->PCAF->H3 acetylation as a requirement for LCR-promoter looping connected a specific histone-modification cascade to chromatin hub formation and transcription.\",\n      \"evidence\": \"In vitro HAT assay, PCAF Co-IP, PRMT1 knockdown/rescue, ChIP and 3C in MEL erythroid progenitors\",\n      \"pmids\": [\"20068219\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Recruitment of PRMT1 to the locus not defined\", \"Interplay with other locus-bound factors not mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing KLF1 controls switching through BCL11A clarified that beta activation and gamma repression are partly separable arms of the same factor's program.\",\n      \"evidence\": \"shRNA KLF1 knockdown in human and mouse adult erythroid progenitors with qRT-PCR of BCL11A and globins\",\n      \"pmids\": [\"20676097\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct KLF1 binding at BCL11A not shown here\", \"Quantitative contribution of direct beta activation versus BCL11A axis unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying Nipbl-dependent cohesin binding as required for LCR-gene looping added the architectural machinery underpinning the active chromatin hub.\",\n      \"evidence\": \"ChIP for cohesin/Nipbl, 3C, and Nipbl siRNA in differentiating MEL and primary erythroid cells\",\n      \"pmids\": [\"21454523\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cohesin selects the LCR-promoter contact not defined\", \"Relationship to PRMT1/PCAF cascade not integrated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating sequence-specific binding and repression by nuclear ferritin-H revealed a negative regulatory input at the beta-globin promoter.\",\n      \"evidence\": \"EMSA with purified ferritin-H, promoter mutagenesis, and reporter cotransfection with EKLF\",\n      \"pmids\": [\"11481480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological conditions triggering ferritin-H repression not defined\", \"Role at the endogenous locus not established\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapping Suv39H/G9a-dependent H3K9 methylation to nuclear peripheral tethering linked locus positioning to specific chromatin marks.\",\n      \"evidence\": \"BAC transgenesis, FISH, Suv39H/G9a knockdown, and H3K9me2/3 ChIP\",\n      \"pmids\": [\"24297746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of peripheral positioning for transcription not resolved\", \"Lamin-association readers not identified\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Localizing the nonsense-mutation defect to a nuclear/pre-cytoplasmic step distinguished beta-thalassemia mRNA loss from cytoplasmic instability, foreshadowing nuclear surveillance.\",\n      \"evidence\": \"Transfection into ts-Pol II cells with separate assays of transcription, stability, splicing, and polyadenylation; prior allelic series of five nonsense mutations\",\n      \"pmids\": [\"1557399\", \"3353367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Surveillance machinery not molecularly identified in these studies\", \"Position-dependence of the effect not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Therapeutic CRISPR/Cas12a disruption of aberrant splice sites in patient HSPCs demonstrated that correcting beta-globin splicing restores functional protein, validating splicing mutations as the disease driver.\",\n      \"evidence\": \"CRISPR RNP electroporation of patient CD34+ HSPCs, erythroid differentiation, splicing RT-PCR and globin HPLC; gene-targeted IVS2-654 mouse model\",\n      \"pmids\": [\"30704988\", \"9490703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term engraftment and off-target effects not addressed here\", \"Generalizability across mutation classes not fully tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing that reducing beta-globin itself triggers ATF4/MYB/BCL11A-dependent gamma-globin re-expression revealed a feedback stress response coupling beta levels to fetal globin.\",\n      \"evidence\": \"CRISPR HBB knockout in isogenic erythroid precursors with RNA-seq and ATF4 ChIP at the HBS1L-MYB enhancer\",\n      \"pmids\": [\"32755585\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab pathway placement\", \"Direct versus indirect ATF4 effects on globins not fully separated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identifying HBB as a lung-derived antimetastatic factor with an active C-terminal peptide established a non-erythroid extracellular function.\",\n      \"evidence\": \"Peptide mapping of lung factors, in vitro apoptosis assays, and xenograft metastasis models\",\n      \"pmids\": [\"27793844\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor/mechanism of the Metox peptide not defined\", \"Single-lab non-erythroid context\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defining HBB as a direct aconitine target that promotes ABHD5/AMPK binding and NO scavenging linked HBB to cardiotoxicity outside its canonical role.\",\n      \"evidence\": \"Cell-free AC-HBB binding, HBB overexpression/knockdown in cardiomyocytes, Co-IP with ABHD5 and AMPK, S-nitrosylation measurement\",\n      \"pmids\": [\"38467717\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab Co-IP without reciprocal/structural validation\", \"Physiological relevance beyond aconitine exposure unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the histone-modification cascade, cohesin architecture, and erythroid transcription factors are mechanistically integrated to nucleate and maintain the active chromatin hub remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of assembly of PRMT1/PCAF, cohesin, and KLF1 at the locus not established\", \"How non-erythroid HBB functions relate to the hemoglobin tetramer not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [14, 18, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 19, 22, 24]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [22, 25]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [4, 5, 11, 12]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [13, 14, 23]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [26, 27, 29]}\n    ],\n    \"complexes\": [\"active chromatin hub (LCR-beta-globin)\"],\n    \"partners\": [\"KLF1\", \"BCL11A\", \"PRMT1\", \"PCAF\", \"cohesin/Nipbl\", \"ferritin-H\", \"ABHD5\", \"AMPK\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}